SCHENA, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.306
AS - Asia 2.274
EU - Europa 1.542
SA - Sud America 559
AF - Africa 102
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 9.795
Nazione #
US - Stati Uniti d'America 5.210
SG - Singapore 935
CN - Cina 516
BR - Brasile 447
SE - Svezia 321
HK - Hong Kong 259
RU - Federazione Russa 239
IT - Italia 199
DE - Germania 195
VN - Vietnam 171
FI - Finlandia 144
FR - Francia 123
GB - Regno Unito 117
IN - India 82
BD - Bangladesh 51
CA - Canada 46
UA - Ucraina 42
AR - Argentina 34
BE - Belgio 34
TR - Turchia 33
ID - Indonesia 32
MX - Messico 31
IQ - Iraq 30
JP - Giappone 26
ZA - Sudafrica 26
NL - Olanda 25
PL - Polonia 25
CI - Costa d'Avorio 24
SA - Arabia Saudita 21
CO - Colombia 20
EC - Ecuador 19
UZ - Uzbekistan 15
PH - Filippine 14
AT - Austria 13
MA - Marocco 12
PK - Pakistan 12
LT - Lituania 11
ES - Italia 10
IE - Irlanda 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
VE - Venezuela 9
MY - Malesia 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
PY - Paraguay 7
AU - Australia 6
BO - Bolivia 6
CL - Cile 6
EG - Egitto 6
IL - Israele 6
LB - Libano 6
ET - Etiopia 5
KW - Kuwait 5
DZ - Algeria 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
TH - Thailandia 4
AO - Angola 3
AZ - Azerbaigian 3
CR - Costa Rica 3
NI - Nicaragua 3
PT - Portogallo 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
AQ - Antartide 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CM - Camerun 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 9.783
Città #
Ashburn 614
Fairfield 565
Singapore 491
Chandler 406
Woodbridge 328
San Jose 311
Houston 261
Nyköping 259
Hong Kong 258
Ann Arbor 255
Cambridge 231
Seattle 215
Wilmington 171
Beijing 170
New York 120
Helsinki 104
Los Angeles 85
Dearborn 75
Jacksonville 75
Lawrence 75
Roxbury 75
Lauterbourg 74
Nanjing 73
Dallas 70
Munich 67
Ho Chi Minh City 58
Bari 56
Council Bluffs 48
Des Moines 46
São Paulo 44
Santa Clara 41
Inglewood 39
Hanoi 36
Brooklyn 35
Brussels 34
San Diego 27
Abidjan 24
Buffalo 24
Warsaw 24
Chicago 22
Jakarta 22
Shenyang 21
Tokyo 21
Frankfurt am Main 20
Montreal 20
Orem 19
Boardman 18
Turku 18
Amsterdam 17
London 17
Stockholm 17
Atlanta 16
Dong Ket 16
Falkenstein 16
Nanchang 16
Hebei 15
Jiaxing 15
Johannesburg 15
Toronto 15
Guangzhou 14
Phoenix 14
Nuremberg 13
Princeton 13
San Francisco 13
Tashkent 13
Boston 12
Hefei 12
Paris 12
Rio de Janeiro 12
Chennai 11
The Dalles 11
Columbus 10
Curitiba 10
Dhaka 10
Redwood City 10
Ankara 9
Baghdad 9
Brasília 9
Denver 9
Dublin 9
Mexico City 9
Ribeirão Preto 9
Biên Hòa 8
Da Nang 8
Guayaquil 8
Kunming 8
Leawood 8
Milan 8
Poplar 8
Pune 8
Riyadh 8
Salt Lake City 8
Bitonto 7
Brno 7
Changsha 7
Jeddah 7
Jinan 7
Nairobi 7
San Mateo 7
Taranto 7
Totale 6.709
Nome #
Inhibin-A and Decorin Secreted by Human Adult Renal Stem/Progenitor Cells Through the TLR2 Engagement Induce Renal Tubular Cell Regeneration 209
Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy 201
Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients 194
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy 187
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 169
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 167
ABNORMAL METHYLATED DNA REGIONS INDICATE AN ATYPICAL RESPONSE OF THE CD4+ T CELLS IN IGA NEPHROPATHY PATIENTS 167
A transcriptomic study of Hereditary Angioedema attacks 155
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 149
Cultivar classification of Apulian olive oils: Use of artificial neural networks for comparing NMR, NIR and merceological data 147
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 141
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 140
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 139
Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases 137
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 129
Complement-mediated acute induction of endothelial-to-mesenchymal transition (EndMT) in a swine model of renal ischemia/reperfusion (I/R) injury 128
AQP5: Renal Aquaporins Family Got a New Member 127
MP065 ABERRANT METHYLATED DNA REGIONS LEAD TO LOW ACTIVATION OF CD4+ T CELLS WITH A CONSEQUENT IMBALANCE OF THE TH1/TH2 POLARIZATION IN IGA NEPHROPATHY PATIENTS 124
Micropatterning control of tubular commitment in human adult renal stem cells 123
A kinetic test for the assay of the C1 esterase-inhibitor 123
Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy 122
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis 120
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 119
Potential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney Injury 118
Activated Factor X Induces Peripheral Blood Mononuclear Cells Activation During Hemodialysis 117
Activation of NADPH oxidase and coagulation cascade in renal ischemia-reperfusion (I/R) 116
ADULT RENAL STEM/PROGENITOR CELLS REPAIR ACUTE RENAL TUBULAR CELL INJURY BY MEANS OF SPECIFIC TLR2-DRIVEN PARACRINE FACTORS 115
ALTERED MONOCYTE GENE EXPRESSION AND EXPANSION OF CD14 (+) CD16 (+) CELL SUBSET IN IgA NEPHROPATHY PATIENTS 114
COVID-19 and kidney transplantation: an Italian Survey and Consensus 113
ISCHEMIA AND ISCHEMIA-REPERFUSION (I/R) INDUCE GLOMERULAR AND TUBULAR AKT AND NIK ACTIVATION IN HUMAN (H) AND PIG (P) KIDNEYS 112
AKI and stem cells 112
RENAL EXPRESSION OF MONOCYTE CHEMOTATIC PROTEIN-1 (MPC-1) AND EPIDERMAL GROW FACTOR (EGF) IN CHILDREN WITH OBDTRUCTIVE HYDRONEPHROSIS 109
A COMBINED MIRNA BIOMARKER FOR NON-INVASIVE DIAGNOSIS OF IDIOPATHIC IGA NEPHROPATHY: AN INTERNATIONAL MULTICENTRE STUDY (NIDIGAN STUDY) 108
null 108
ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA) AND PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR (PDGF-BETA-R) EXPRESSION IN HUMAN-IGA NEPHROPATHY (IGAN) - A TUBULOINTERSTITIAL CORRELATION 108
Immunosuppressive agents for treating IgA nephropathy 108
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 107
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: Role of NF-κB and Lyn 107
MicroRNAs in glomerular diseases from pathophysiology to potential treatment target 104
Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation 102
null 101
Omics studies for comprehensive understanding of immunoglobulin A nephropathy: State-of-the-art and future directions 101
IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection 100
Coagulation activation induces increased NADPH-dependent reactive oxygen species (ROS) generation in haemodialysis (HD) 99
AKT activation may represent the molecular link between rapamycin (RAPA) treatment and insulin-resistance in renal transplant recipients. 99
Iga Nephropathy and urinary proteomics 98
MicroRNAs in Kidney Diseases 98
Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients 98
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy 98
NMR-based metabolomic study of Apulian Coratina extra virgin olive oil extracted with a combined ultrasound and thermal conditioning process in an industrial setting 96
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 96
null 93
IDENTIFICATION OF QUANTITATIVE TRAIT LOCI FOR DEGLYCOSYLATED IGA1 SERUM LEVELS IN FAMILIAL IGA NEPHROPATHY 92
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 90
An end stage kidney disease predictor based on an artificial neural networks ensemble 90
A bioartificial renal tubule device embedding human renal stem/progenitor cells 90
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment 89
A proton nuclear magnetic resonance-based metabolomic approach in IgA nephropathy urinary profiles 89
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION 89
MicroRNAs in kidney diseases: New promising biomarkers for diagnosis and monitoring 88
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 88
Multiple rare genetic variants co‐segregating with familial IgA nephropathy all act within a single immune‐related network 87
Low coagulation-activating dialyzer reduces progression of atherosclerosis in hemodialysis modulatig serum bone morphogenetic proteins (BMPs) 86
DRG's and cost/efficacy indicators in nephrology and dialysis. Results at a hospital division 81
Patient classification and outcome prediction in IgA nephropathy 80
Erratum: Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy (Nephrology Dialysis Transplantation (2009) DOI: 10.1093/ndt/gfp356) 78
Altered modulation of WNT–β-catenin and PI3K/Akt pathways in IgA nephropathy 77
Determination of hydroxytyrosol and tyrosol in human urine after intake of extra virgin olive oil produced with an ultrasounds-based technology 77
From-omics to personalized medicine in nephrology: Integration is the key 75
Immunosuppressive agents for treating IgA nephropathy 75
RARE GENETIC VARIANTS IMPLICATED IN INNATE AND ADAPTIVE IMMUNITY CO-SEGREGATE WITH FAMILIAL IGA NEPHROPATHY 74
Pharmacogenomics: A new paradigm to personalize treatments in nephrology patients 74
Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients 73
C5b-9 generation and cytokine production in hemodialyzed patients 69
null 69
null 69
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells 69
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy 66
LINKAGE ANALYSIS DETECTES TWO ADDITIONAL REGIONS IN FAMILIAL IGA NEPHROPATHY 65
null 65
β3 adrenergic receptor as potential therapeutic target in ADPKD 64
OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR) 63
IgAN Genetic Risk Score in the Clinical Setting 62
null 62
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients 61
Epidemiology and ancestral difference 60
GENOME-WIDE SCAN OF COPY NUMBER VARIATIONS (CNVS) IDENTIFIES A VARIABLE REGION AT 3P21. 1 REGULATING THE TLR9 EXPRESSION IN IGA NEPHROPATHY PATIENTS 58
MIR-148B UPREGULATION MODULATING CORE 1, B1, 3-GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IGA1 IN IGA NEPHROPATHY 56
Genome-wide association studies in kidney diseases: Quo Vadis 54
Kidney and urine cell transcriptomics in IgA nephropathy and lupus nephritis: a narrative review 52
null 52
null 52
Searching for IgA nephropathy candidate genes: Genetic studies combined with high throughput innovative investigations 51
Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy 51
Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy 51
null 50
New directions in the pathogenesis of primary erythrocytosis in IgAN 49
null 49
Biomarkers and Precision Medicine in IgA Nephropathy 48
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 47
Totale 9.778
Categoria #
all - tutte 43.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 0 0 0 0 116 87 74
2021/2022617 33 38 8 28 22 61 14 31 44 78 90 170
2022/2023998 106 162 84 82 101 150 13 118 144 7 17 14
2023/2024365 33 47 12 34 31 115 4 20 13 10 9 37
2024/20251.673 44 46 116 56 71 116 181 156 53 90 257 487
2025/20263.479 562 163 205 417 491 244 408 112 496 381 0 0
Totale 10.144